COMMUNIQUÉS West-GlobeNewswire

Extendicare Announces Voting Results from the 2019 Annual and Special Meeting of Shareholders and Board Changes
31/05/2019
MARKHAM, Ontario, May 30, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual and special shareholders’ meeting held on May [...]
Revive Therapeutics Announces Results for the Three and Nine Months Ended March 31, 2019
31/05/2019
TORONTO, May 30, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) ("Revive" or the “Company”) , a specialty cannabis company focused on the research, development and [...]
Helix BioPharma Corp. Initiates OTCQB Application and Hires U.S. Investor Relations Firm
30/05/2019
RICHMOND HILL, Ontario, May 30, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of [...]
Atara Biotherapeutics to Participate at Two Upcoming Investor Conferences
30/05/2019
SOUTH SAN FRANCISCO, Calif., May 30, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Aurora Spine Corporation Reports Record Q1 Revenue; Files Condensed Interim Consolidated Financial Statements For the Three Months Ended March 31, 2019
30/05/2019
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., May 30, 2019 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces financial [...]
Cambium Networks Files Registration Statement with SEC for an Initial Public Offering
30/05/2019
ROLLING MEADOWS, Ill., May 30, 2019 (GLOBE NEWSWIRE) -- Cambium Networks Corporation (“Cambium”), a provider of wireless broadband networking infrastructure solutions, today announced that it has filed a registration [...]
U.S. FDA Grants Priority Review for Daratumumab in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
30/05/2019
Company Announcement U.S. FDA grants Priority Review for daratumumab in combination with bortezomib, thalidomide and dexamethasone as treatment for newly diagnosed patients with multiple myeloma who are candidates for [...]
Dentsply Sirona to Present at the 2019 William Blair Growth Stock Conference on June 6th
30/05/2019
CHARLOTTE, N.C., May 30, 2019 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that it will participate in the 2019 William Blair Growth Stock [...]
XBiotech Announces Public Offering of Common Shares
30/05/2019
AUSTIN, Texas, May 30, 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) today announced that it has commenced an underwritten public offering of common shares, subject to market and other conditions. XBiotech [...]
Zynerba Pharmaceuticals to Present at FDA’s Public Hearing on Scientific Data and Information about Products Containing Cannabis or Cannabis-derived Compounds
30/05/2019
DEVON, Pa., May 30, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Osmotica Pharmaceuticals plc to Present at Jefferies 2019 Global Healthcare Conference
30/05/2019
BRIDGEWATER, N.J., May 30, 2019 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced that Brian Markison, Chief [...]
Retrophin to Present at Upcoming Investor Conferences
30/05/2019
SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that Company management will present at the following upcoming investor conferences in June: Jefferies 2019 Global Healthcare [...]
Intellia Therapeutics to Participate at June Healthcare Investor Conferences
30/05/2019
CAMBRIDGE, Mass., May 30, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex [...]
Adamas Pharmaceuticals Welcomes Vijay Shreedhar as Chief Commercial Officer
30/05/2019
EMERYVILLE, Calif., May 30, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system (CNS) disorders [...]
CB2 Insights Posts Strong Growth in Clinical Revenue and Drives Operating Efficiencies in Q1 2019
30/05/2019
16% Increase in Quarter-over-Quarter Revenue; Quarterly Expense Reduction of 17% TORONTO, May 30, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB:CBIIF) (“ CB2 ” or the “ Company ”), a leading technology company [...]
Globus Medical Launches First Expandable Interspinous Fixation – AERIAL™
30/05/2019
Innovating Interspinous Fixation with Expandable Technology AUDUBON, Pa., May 30, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the launch of [...]
The Cooper Companies Announces Second Quarter 2019 Results
30/05/2019
PLEASANTON, Calif., May 30, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) today announced financial results for the fiscal second quarter ended April 30, 2019. Revenue increased 4% year-over-year to $ [...]
Cytori Announces New Annual Stockholders Meeting Date for June 18
30/05/2019
May 28 Meeting Adjourned to Provide Additional Time to Obtain Approval of Key Business SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX) today announced that it convened its annual [...]
Merus Announces Financial Results for the First Quarter 2019 and Provides Business Update
30/05/2019
UTRECHT, The Netherlands, May 30, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human [...]

Pages